just to ensure I have understood you correctly, are you suggesting no “new” CQA’s or potency assays have been generated.
but rather they have generated new data to bolster their existing CQA and potency assays on TNFR1 and IL
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-140
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.39 |
Change
-0.005(0.36%) |
Mkt cap ! $1.581B | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.42 | $1.38 | $2.933M | 2.103M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 49460 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.39 | 14631 | 20 |
View Market Depth
| Last trade - 14.14pm 10/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |